ImExHS Limited
ASX: IME
Growth driven by expanding Aquila platform contracts.
(Source: TradingView) 3-Month Performance Profile of IME on a DTF compared to S&P/ASX 200 (XJO).
IMEXHS reported 1H FY25 revenue of $13.7 million, supported by growing adoption of Aquila, its next-generation cloud-based radiology platform, which continues to gain traction across Latin America. Commercial momentum
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
Daily Digest
A$200.00
Already a subscriber?
Sign in to read this report.
Required subscription
Daily Digest
Stay informed with expert daily ASX research covering four carefully selected stocks, complete with market insights, risk ratings, and clear Buy, Hold, or Sell general guidance—delivered before the market opens each trading day.
- ✓ Four Expert-Selected ASX Stocks Daily
- ✓ Weekday Pre-Market Delivery
- ✓ In-Depth Research & Analysis
- ✓ Access to All Previous Reports
A$200.00/ 12 months
Risk:Medium
Subscribe Now →
